NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

氣喘藥市場調查報告:各產品(長期管理藥,過敏誘發性氣喘治療藥,及快浮雕藥),各用途-至2025年的預測-COVID-19累積的影響

Asthma Drugs Market Research Report by Product (Long-term control medications, Medications for allergy-induced asthma, and Quick-relief medications ), by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1000968
出版日期 內容資訊 英文 188 Pages
商品交期: 最快1-2個工作天內
價格
氣喘藥市場調查報告:各產品(長期管理藥,過敏誘發性氣喘治療藥,及快浮雕藥),各用途-至2025年的預測-COVID-19累積的影響 Asthma Drugs Market Research Report by Product (Long-term control medications, Medications for allergy-induced asthma, and Quick-relief medications ), by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 188 Pages
簡介

全球氣喘治療藥的市場規模,預計從2020年的148億3,758萬美元,至2025年末成長為213億8,279萬美元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。目前進行的調查擴大了框架,以確保包括潛在的COVID-19問題和發展途徑。本報告提供有關COVID-19的見解,其中考慮了消費者行為和需求的變化,購買方式,供應鏈的新路由,當前市場力量的動態以及政府的重要介入等COVID-19對市場的影響相關洞察。更新的調查,考慮市場上COVID-19的影響,提供洞察,分析,估計,及預測。

本報告提供氣喘藥市場相關調查,市場概要,以及各產品,各用途,各地區的趨勢,COVID-19累積的影響,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和範圍
  • 調查對象年
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃作成
    • 實行:調查實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場預測
  • 各產品預測
  • 各用途預測
  • 各地區預測
  • 其他各競爭公司預測

第4章 市場概要

  • 簡介
  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特五力分析
    • 新加入業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 全球氣喘治療藥市場,各產品

  • 長期管理藥
  • 過敏誘發性氣喘治療藥
  • 援救藥

第7章 全球氣喘治療藥市場,各用途

  • 醫院藥局
  • 線上藥局
  • 零售藥局

第8章 南北美洲的氣喘藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區的氣喘治療藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東、非洲的氣喘治療藥市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • Aerocrine (Circassia)
  • ALK-Abello A/S
  • Amphastar Pharmaceuticals, Inc.
  • AstraZeneca
  • Boehringer Ingelheim
  • Camber Pharmaceuticals
  • Chiesi Farmaceutici
  • Cipla
  • Cohero Health
  • GlaxoSmithKline PLC
  • Inspiro Medical (Opko Health)
  • Lallemand Pharma International
  • Merck & Co., Inc.
  • MundiPharma
  • Novartis AG
  • Pulmatrix
  • Roche Holding AG
  • Sanner GmbH
  • Sanofi/Regeneron
  • Sunovion
  • Teva
  • Theravance Biopharma¦Mylan Inc.
  • Vectura Group plc
  • Verona Pharma plc

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-434CCDA05233

The Global Asthma Drugs Market size was estimated at USD 14.83 Billion in 2020 and expected to reach USD 16.03 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 8.42% to reach USD 24.10 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Asthma Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Asthma Drugs Market was studied across Long-term control medications, Medications for allergy-induced asthma, and Quick-relief medications (rescue medications).

Based on Application, the Asthma Drugs Market was studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.

Based on Geography, the Asthma Drugs Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Asthma Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Asthma Drugs Market, including Aerocrine (Circassia), ALK-Abello A/S, Amphastar Pharmaceuticals, Inc., AstraZeneca, Boehringer Ingelheim, Camber Pharmaceuticals, Chiesi Farmaceutici, Cipla, Cohero Health, GlaxoSmithKline PLC, Inspiro Medical (Opko Health), Lallemand Pharma International, Merck & Co., Inc., MundiPharma, Novartis AG, Pulmatrix, Roche Holding AG, Sanner GmbH, Sanofi/Regeneron, Sunovion, Teva, Theravance Biopharma|Mylan Inc., Vectura Group plc, and Verona Pharma plc.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Asthma Drugs Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Asthma Drugs Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Asthma Drugs Market?
  • 4. What is the competitive strategic window for opportunities in the Global Asthma Drugs Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Asthma Drugs Market?
  • 6. What is the market share of the leading vendors in the Global Asthma Drugs Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Asthma Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Application Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of asthma globally
      • 5.1.1.2. Increasing acceptance of asthma drugs with approval from FDA
      • 5.1.1.3. Government initiatives fuels the awareness of asthma drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Expiry of patent drugs and high penetration of generic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the development of asthma drugs
      • 5.1.3.2. Introduction of generic drugs in developing regions
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations for the approval of asthma drugs
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Asthma Drugs Market, by Product

  • 6.1. Introduction
  • 6.2. Long-term control medications
  • 6.3. Medications for allergy-induced asthma
  • 6.4. Quick-relief medications (rescue medications)

7. Asthma Drugs Market, by Application

  • 7.1. Introduction
  • 7.2. Hospital Pharmacy
  • 7.3. Online Pharmacy
  • 7.4. Retail Pharmacy

8. Americas Asthma Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Asthma Drugs Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Asthma Drugs Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Aerocrine (Circassia)
  • 12.2. ALK-Abello A/S
  • 12.3. Amphastar Pharmaceuticals, Inc.
  • 12.4. AstraZeneca
  • 12.5. Boehringer Ingelheim
  • 12.6. Camber Pharmaceuticals
  • 12.7. Chiesi Farmaceutici
  • 12.8. Cipla
  • 12.9. Cohero Health
  • 12.10. GlaxoSmithKline PLC
  • 12.11. Inspiro Medical (Opko Health)
  • 12.12. Lallemand Pharma International
  • 12.13. Merck & Co., Inc.
  • 12.14. MundiPharma
  • 12.15. Novartis AG
  • 12.16. Pulmatrix
  • 12.17. Roche Holding AG
  • 12.18. Sanner GmbH
  • 12.19. Sanofi/Regeneron
  • 12.20. Sunovion
  • 12.21. Teva
  • 12.22. Theravance Biopharma|Mylan Inc.
  • 12.23. Vectura Group plc
  • 12.24. Verona Pharma plc

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ASTHMA DRUGS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL ASTHMA DRUGS MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL ASTHMA DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 10. GLOBAL ASTHMA DRUGS MARKET SIZE, BY LONG-TERM CONTROL MEDICATIONS, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL ASTHMA DRUGS MARKET SIZE, BY LONG-TERM CONTROL MEDICATIONS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL ASTHMA DRUGS MARKET SIZE, BY MEDICATIONS FOR ALLERGY-INDUCED ASTHMA, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL ASTHMA DRUGS MARKET SIZE, BY MEDICATIONS FOR ALLERGY-INDUCED ASTHMA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL ASTHMA DRUGS MARKET SIZE, BY QUICK-RELIEF MEDICATIONS (RESCUE MEDICATIONS), 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL ASTHMA DRUGS MARKET SIZE, BY QUICK-RELIEF MEDICATIONS (RESCUE MEDICATIONS), BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 17. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 19. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2026 (USD BILLION)
  • FIGURE 20. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 21. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2026 (USD BILLION)
  • FIGURE 22. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 23. GLOBAL ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 26. AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 28. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 29. BRAZIL ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 30. CANADA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 31. MEXICO ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 32. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 33. CALIFORNIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 34. FLORIDA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 35. ILLINOIS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 36. NEW YORK ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 37. OHIO ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 38. PENNSYLVANIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 39. TEXAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 40. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 41. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 43. CHINA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 44. INDIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 45. INDONESIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. JAPAN ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. THAILAND ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 52. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 54. FRANCE ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. GERMANY ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. ITALY ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. QATAR ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. RUSSIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. SPAIN ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. GLOBAL ASTHMA DRUGS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 66. GLOBAL ASTHMA DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 67. GLOBAL ASTHMA DRUGS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ASTHMA DRUGS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ASTHMA DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL ASTHMA DRUGS MARKET SIZE, BY LONG-TERM CONTROL MEDICATIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL ASTHMA DRUGS MARKET SIZE, BY MEDICATIONS FOR ALLERGY-INDUCED ASTHMA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL ASTHMA DRUGS MARKET SIZE, BY QUICK-RELIEF MEDICATIONS (RESCUE MEDICATIONS), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. AMERICAS ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. AMERICAS ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. BRAZIL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. BRAZIL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. CANADA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. CANADA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. MEXICO ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. MEXICO ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. CALIFORNIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. CALIFORNIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. FLORIDA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. FLORIDA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. ILLINOIS ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. ILLINOIS ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. NEW YORK ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. NEW YORK ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. OHIO ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. OHIO ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. PENNSYLVANIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. PENNSYLVANIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. TEXAS ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. TEXAS ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. CHINA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. CHINA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. INDIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. INDIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. INDONESIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. INDONESIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. JAPAN ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. JAPAN ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. THAILAND ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. THAILAND ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. FRANCE ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. FRANCE ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. GERMANY ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. GERMANY ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. ITALY ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. ITALY ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. QATAR ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. QATAR ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. RUSSIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. RUSSIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. SPAIN ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. SPAIN ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. GLOBAL ASTHMA DRUGS MARKET: SCORES
  • TABLE 84. GLOBAL ASTHMA DRUGS MARKET: BUSINESS STRATEGY
  • TABLE 85. GLOBAL ASTHMA DRUGS MARKET: PRODUCT SATISFACTION
  • TABLE 86. GLOBAL ASTHMA DRUGS MARKET: RANKING
  • TABLE 87. GLOBAL ASTHMA DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 88. GLOBAL ASTHMA DRUGS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 89. GLOBAL ASTHMA DRUGS MARKET: MERGER & ACQUISITION
  • TABLE 90. GLOBAL ASTHMA DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 91. GLOBAL ASTHMA DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 92. GLOBAL ASTHMA DRUGS MARKET: INVESTMENT & FUNDING
  • TABLE 93. GLOBAL ASTHMA DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 94. GLOBAL ASTHMA DRUGS MARKET: LICENSE & PRICING
  • TABLE 95. GLOBAL ASTHMA DRUGS MARKET: CONTACT DETAILS